Thursday, March 22, 2012

Merck Flushing Drug May Tackle Baldness - Mar. 22, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Thursday, March 22, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Reduce Risk and Maximize Potential in Ophthalmology Development

Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development.

The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
HeadHtml
•  Merck & Co., Inc. (MRK) Flushing Drug May Tackle Baldness More...
•  Blood Test May Give Early Warning on Heart Attack, Scripps Translational Science Institute Study More...
•  Obesity Harms "Later Brain Skill," Alzheimer's Society Reveals More...
•  Fatty Meals Could Trigger Inflammation for Diabetics, University of Warwick Study More...
•  New Findings Show Soy May Alleviate Hot Flashes, Institute of Health and Nutrition Study More...
More General Clinical Research News
HeadHtml
•  Perrigo Company (PRGO) Announces Australian Approval for Generic Temozolomide More...
More Drug Approval News
HeadHtml
•  Talon Therapeutics, Inc. (HNAB)' Marqibo(R) Wins Backing of FDA Advisory Panel More...
More PDUFA News
HeadHtml
•  Pozen, Inc. (POZN)'s PA32540 Meets Goals in Pivotal Phase 3 Studies More...
•  Trimel Reports Positive Pharmacokinetic Tefina Study Results More...
•  Starpharma Holdings Ltd Commences Pivotal Phase 3 Vivagel® Trials for Bacterial Vaginosis Treatment More...
•  BHR Pharma, LLC's SyNAPSe® Trial Reaches Important Enrollment Milestone on Brain Injury Awareness Day More...
•  MediciNova, Inc. Completes Enrollment in Phase 2 MN-221 Trial Treating Patients Suffering from Acute Exacerbations of Asthma More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
Events

CHI's 8th Annual
PEGS: The Protein Engineering Summit
April 30- May 4 | Boston, MA
www.PEGSummit.com

Advance Registration Deadline is Friday, March 23
Register now and save up to $200!

Cambridge Healthtech Institute is proud to present the Eighth Annual PEGS protein engineering summit. This comprehensive event encompasses 12 tracks, 15 short courses, and a pre-conference partnering forum for showcasing early stage companies. Topics span from early stage discovery of new methods for protein expression and antibody engineering, to improved analytical techniques, and clinical results in the most promising areas of biotechnology. There is tremendous momentum and investment in biologics, and the PEGS event offers an unparalleled view of the field. Make plans to join us this April in Boston.

To register and for more information, visit www.PEGSummit.com.
Latest Market Insight

New Emerging R&D and Clinical Trial Locations

• Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity.
• Analyze how clinical trial numbers are changing in China, India, and Eastern Europe.
• Develop strategies for geographic outsourcing.

Click Here for More Information.
Tower: Facebook
Top Jobs
Pharm Country (Frazer, Pennsylvania)

DoubleStar, Inc.
Local Clinical Trial Manager
Oversee and manage in the conduct of global clinical trials at the region level for all clinical phases (I, clin pharm, II, III and IV) via the help of CROs and vendors. Manage the study if a single country study. Provide co-monitoring and assist global trials for this Regions by working as a partner with the Global Trial Manager (GTM).

Genetown (Cambridge, Massachusetts)

Vertex
Clinical Data Management Lead
Responsible for a variety of technical and leadership duties including accurate and consistent reporting and documentation within GIS, Application Development. The Lead ensures that projects are completed in a timely manner and meet the required objectives.

Biotech Beach (San Diego, California)

Fate Therapeutics, Inc.
Clinical Research Associate II
Manage internal and external monitoring and administrative aspects of phase I/II multi-center trial from study initiation to completion/close-out. Travel to clinical sites, and arrange own schedule and travel arrangements for qualification, initiation, routine and study close-out monitoring visits.

Biotech Bay (Brisbane, California)

InterMune, Inc.
Clinical Program Manager
Responsible for managing new and/or ongoing clinical trials. This position will direct all operational activities resulting in the clinical study being conducted in a successful manner according to specified timelines and budget.

Southern Pharm (Gainesville, Florida)

Ipsen
Endo Clinical Science Specialist
Responsible for the sales of Increlex, Somatuline Depot and other products as they become available, to clinicians in his/her area of responsibility. The CSS will sell the values, features and benefits of Ipsen and its products to customers within the assigned territory.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Pharm Country

Pharm Country Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Pharm Country Career Fair, Bridgewater, NJ March 22, 2012
Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Apricus Biosciences (APRI) Announces Allowance of a NexACT(R) Technology-Based Patent in Europe for the Manufacture of DDAIP More...
More Patent News
HeadHtml
•  Covidien (COV)'s Mallinckrodt Inc. Business Launches Morphine Sulfate Oral Solution in U.S. More...
•  AstraZeneca PLC (AZN) Announces Increased Coverage of BRILINTA (Ticagrelor) Through Plan Preferred Formulary Status on Medco Health Solutions, Inc. More...
•  Corcept Therapeutics Inc. (CORT)'s Korlym™ (mifepristone), the First Approved Medication for Patients With Endogenous Cushing's Syndrome, to be Available by April 11 More...
More Drug Product News
Feature

Hot Company

Gentris Corporation
133 Southcenter Court, Suite 400
Morrisville, North Carolina 27560 U.S.A.
Phone: 919-465-0100 Fax: 919-465-0554

Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services. As pioneers in the field of pharmacogenomics, Gentris assists pharmaceutical companies and clinical research organizations to effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective drugs to market more quickly.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: